Rocket Lab’s $266 Million Space Force Win Can’t Mask the $3.6 Billion Elephant in the Room
Published on 07/30/2026 at 14:11 | Redaktion boerse-global.de
Rocket Lab’s stock is caught in a tug-of-war between operational momentum and financial anxiety. Shares edged up 1.56 percent to €52.00 on Wednesday, a modest bounce from the prior session’s close of €51.20, but that does little to mask a brutal 30-day stretch that has wiped 41.57 percent from the stock. From its May peak of €133.80, the equity has cratered 61.14 percent — a decline that has little to do with how the company is executing on its core business.
The culprit is financing, not operations. Rocket Lab’s planned $8 billion acquisition of Iridium Communications, announced in late June, has spooked investors with its capital structure. The company secured a $3.6 billion bridge loan to cover the cash portion of the deal, with the remainder to be funded through existing cash, additional debt, and equity. That cocktail of leverage and dilution risk is hitting a business that generated roughly $680 million in revenue over the past twelve months and is still unprofitable. With an annualized 30-day volatility reading of 91.68 percent, the stock is prone to violent swings — and the Iridium financing question has provided the catalyst.
The operational story, by contrast, has rarely looked stronger. On July 21, the US Space Force awarded Rocket Lab a record $266 million contract for twelve suborbital launch missions from the Pacific Spaceport Complex in Kodiak, Alaska, with an option for six more. It is the largest US government launch contract in the company’s history. Days earlier, the Space Force also handed Rocket Lab its first geostationary satellite order — $89.5 million to build two GEO satellites, opening an entirely new market segment. The company also set a new responsiveness record under the TacRS program, launching its own Pioneer satellite aboard an Electron rocket just 16 hours and 42 minutes after notification, and completed a successful qualification test of the Archimedes engine, which will deliver 1.5 million pounds of thrust on the upcoming Neutron rocket.
Should investors sell immediately? Or is it worth buying Rocket Lab?
Yet the stock has largely shrugged off these milestones. The disconnect is stark: the market is pricing financing risk, not operational failure. Adding to the pressure, a broader sell-off in space stocks has dragged Rocket Lab lower. SpaceX, which went public this year, has traded well below its IPO price, triggering a wave of selling across the sector that has swept up Rocket Lab despite its company-specific wins. Even a regulatory tailwind — a FAA proposal to waive environmental reviews for rocket launches, now open for a 30-day comment period — failed to lift the shares on the day it was reported.
The technical picture supports the case for patience. The 14-day relative strength index sits at 30.5, flirting with oversold territory, a level rarely seen outside periods of genuine market stress or company-specific crisis. Over the past twelve months, the stock is still up 27.45 percent, suggesting the long-term uptrend remains intact even if the short-term chart looks grim.
Institutional investors are taking note of the disconnect. Cathie Wood’s ARK Invest purchased roughly 62,500 Rocket Lab shares worth about $4 million on July 28, while simultaneously trimming its Iridium position by nearly 185,000 shares worth $8.4 million — a portfolio adjustment that signals confidence in the combined entity’s prospects. Analysts remain bullish as well, with a consensus price target of €100.40 implying roughly 93 percent upside from current levels. Individual targets range from Bank of America’s $115 to New Street Research’s $150, the highest on the Street. Roth Capital and Citizens both peg the stock at $130.
The Iridium deal, set to close in mid-2027, gives Rocket Lab an instantly operational global satellite network generating $871.7 million in annual revenue with a 57 percent EBITDA margin — avoiding a decades-long build-out. The company’s next quarterly earnings, due August 10, will offer a clearer picture of whether the contract wins from Kodiak and the GEO program are translating into financial results. Until then, the stock remains in a holding pattern: operational strength on one side, a $3.6 billion debt question on the other, and a sector-wide downdraft complicating the math. For investors who can stomach the volatility, the risk-reward calculus tilts toward opportunity — but a quick return to May’s highs looks like a long shot.
Ad
Rocket Lab Stock: New Analysis - 30 July
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
